Omega Fund Management, LLC Nuvation Bio Inc. Transaction History
Omega Fund Management, LLC
- $65.5 Million
- Q4 2024
A detailed history of Omega Fund Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Omega Fund Management, LLC holds 13,072,340 shares of NUVB stock, worth $29.7 Million. This represents 53.05% of its overall portfolio holdings.
Number of Shares
13,072,340
Previous 13,072,340
-0.0%
Holding current value
$29.7 Million
Previous $30.1 Million
15.65%
% of portfolio
53.05%
Previous 44.61%
Shares
9 transactions
Others Institutions Holding NUVB
# of Institutions
168Shares Held
146MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$58.9 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$36.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$35.7 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$20.9 Million5.46% of portfolio
-
Laurion Capital Management LP New York, NY6.49MShares$14.7 Million0.33% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $493M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...